The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair

21.11.24 15:04 Uhr

Werte in diesem Artikel
Aktien

429,75 EUR 2,25 EUR 0,53%

70,63 EUR -2,01 EUR -2,77%

25,21 EUR 0,44 EUR 1,78%

10,51 EUR -0,52 EUR -4,70%

Indizes

PKT PKT

21.289,2 PKT 178,7 PKT 0,85%

19.572,6 PKT 199,8 PKT 1,03%

16.792,5 PKT -32,7 PKT -0,19%

2.915,8 PKT 28,3 PKT 0,98%

5.930,9 PKT 63,8 PKT 1,09%

For Immediate ReleaseChicago, IL – November 21, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Adobe Inc. ADBE, Pfizer Inc. PFE, Dollar General Corp. DG, Snap Inc. SNAP and Ryanair Holdings plc RYAAY.Here are highlights from Wednesday’s Analyst Blog:5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside PotentialU.S. stock markets have been witnessing an impressive rally since the beginning of 2023 barring some minor hurdles. Wall Street’s bull run has got an added boost this year, to the surprise of a large section of financial pandits, who indiscriminately warned of overvaluation.Year to date, the three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — have advanced 14.7%, 24.8%, and 28.6%, respectively. Despite this strong northbound movement, a long list of stocks significantly lagged this year.Nevertheless, an interesting observation is that a handful of these laggards, providing double-digit negative returns year to date, have the potential to return double-digit gains in the short term. Five such stocks with a favorable Zacks Rank are Adobe Inc. , Pfizer Inc., Dollar General Corp., Snap Inc. and Ryanair Holdings plc.Buy 5 Laggards of 2024 with Strong Short-Term Upside PotentialThese five laggards of this year have double-digit upside left for the rest of 2024. Each of our picks carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Adobe Inc.Zacks Rank #2 Adobe has extensively implemented AI applications across its flagship products, such as Photoshop, Illustrator, Lightroom, and Premiere. Earlier this year, ADBE introduced generative AI-driven Adobe Firefly. Moreover, Adobe Acrobat and Reader AI Assistant help users summarize documents and answer questions, saving time and helping users accomplish tasks faster.Using its new AI-driven cloud-based platform, ADBE is also diversifying into digital marketing services, offering data mining services that help businesses measure page views, purchases and social media sites. Adobe Marketing Cloud enables marketers to deliver personalized web experiences across multiple devices, manage multichannel campaigns and optimize media monetization.ADBE has launched Adobe Express, an application for quick editing effects. Leveraging generative AI, this tool is useful for short-form video content like Instagram Reels. Adobe also launched an AI-based Express app for iOS and Android.Impressive Price Upside Potential for ADBE StockThe stock price has plummeted 16.2% year to date. The average short-term price target of brokerage firms represents an increase of 22% from the last closing price of $499.61. The brokerage target price is currently in the range of $440-$703. This indicates a maximum upside of 40.7% and a maximum downside of 12%.Pfizer Inc.Pfizer’s non-COVID operational revenue growth is improving, driven by its key in-line products like Prevnar, Vyndaqel and Eliquis, new launches, and newly acquired products, including those from Seagen. Although revenues from PFE’s COVID-19 products are declining due to lower demand, huge profits from COVID products have strengthened its cash position.The funds are being used to make acquisitions, increase dividends, buy back shares and reduce debt. Seagen’s acquisition has strengthened PFE’s position in the oncology market. Continued growth in non-COVID sales and significant cost-reduction measures should drive PFE’s profit growth.Huge Price Upside Potential for PFE SharesThe stock price has dropped 12.8% year to date. The average short-term price target of brokerage firms represents an increase of 29.1% from the last closing price of $25.10. The brokerage target price is currently in the range of $25-$45. This indicates a maximum upside of 79.3% and no downside.Dollar General Corp.Dollar General remains a compelling growth story in the retail space, despite immediate margin pressure and a tough consumer environment. Thanks to its value-creating initiatives, defensive product mix and real estate growth strategy, DG has the capability to gain market share. DG’s commitment to better pricing, private label offerings, effective inventory management and merchandise initiative should drive sales.We remain encouraged by the host of initiatives such as DG Fresh, SKU rationalization, digitization and the expansion of private fleets that should yield same-store sales improvements and margin expansion. The company emphasizes maintaining and improving cash flow in 2024. Mirroring this optimism is our expectation of same-store sales growth of 1.2% and 1.9% for the current and next fiscal year, respectively.Attractive Price Upside Potential for DG StockThe stock price has plunged 43.7% year to date. The average short-term price target of brokerage firms represents an increase of 24.8% from the last closing price of $76.50. The brokerage target price is currently in the range of $73-$125. This indicates a maximum upside of 63.4% and a maximum downside of 4.6%.Snap Inc.Snap reported strong third-quarter 2024 results. Solid daily active user growth was attributed to the steady adoption of Augmented Reality Lenses, Spotlight and AI chatbot. The Snapchat+ subscription service reached more than 12 million paying subscribers in the third quarter.SNAP made considerable progress in diversifying revenues with Snapchat+ through new artificial intelligence-enabled features. SNAP authorized a new share repurchase program of $500 million. We expect 2024 net sales to rise 15.4% from 2023.Excellent Price Upside Potential for SNAP SharesThe stock price has collapsed 37.9% year to date. The average short-term price target of brokerage firms represents an increase of 24.6% from the last closing price of $10.51. The brokerage target price is currently in the range of $8-$18. This indicates a maximum upside of 71.3% and a maximum downside of 23.9%.Ryanair Holdings plcRyanair Holdings provides scheduled-passenger airline services in Ireland, the United Kingdom, Spain, Italy, and internationally. RYAAY’s measures to expand its fleet, to cater to rising travel demand, look encouraging. The passenger volume has been robust at Ryanair over the past few months owing to the rebound in air-traffic from COVID-19 lows.RYAAY is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services, as well as in-flight sale of beverages, food, duty-free, and merchandise, and markets car hire, travel insurance, and accommodation services through its website and mobile app.Robust Price Upside Potential for RYAAY StockThe stock price has tumbled 15.6% year to date. The average short-term price target of brokerage firms represents an increase of 27.3% from the last closing price of $45.02. The brokerage target price is currently in the range of $52-$62. This indicates a maximum upside of 37.7% and a maximum downside of 15.5%.Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.comPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ryanair Holdings PLC (RYAAY): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock Analysis Report Dollar General Corporation (DG): Free Stock Analysis Report Adobe Inc. (ADBE): Free Stock Analysis Report Snap Inc. (SNAP): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Adobe

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Adobe

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Pfizer Inc.

Analysen zu Pfizer Inc.

DatumRatingAnalyst
19.12.2024Pfizer NeutralUBS AG
17.12.2024Pfizer BuyJefferies & Company Inc.
17.12.2024Pfizer NeutralUBS AG
17.12.2024Pfizer NeutralJP Morgan Chase & Co.
12.12.2024Pfizer NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
17.12.2024Pfizer BuyJefferies & Company Inc.
30.10.2024Pfizer BuyGoldman Sachs Group Inc.
29.10.2024Pfizer BuyJefferies & Company Inc.
27.09.2024Pfizer BuyJefferies & Company Inc.
17.09.2024Pfizer BuyJefferies & Company Inc.
DatumRatingAnalyst
19.12.2024Pfizer NeutralUBS AG
17.12.2024Pfizer NeutralUBS AG
17.12.2024Pfizer NeutralJP Morgan Chase & Co.
12.12.2024Pfizer NeutralJP Morgan Chase & Co.
29.11.2024Pfizer HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
DatumRatingAnalyst
03.05.2018Pfizer VerkaufenDZ BANK
16.05.2017Pfizer SellCitigroup Corp.
27.11.2012Pfizer verkaufenHamburger Sparkasse AG (Haspa)
28.08.2012Pfizer verkaufenHamburger Sparkasse AG (Haspa)
10.01.2012Pfizer verkaufenHamburger Sparkasse AG (Haspa)

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Pfizer Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"